{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T09:14:13Z","timestamp":1785575653553,"version":"3.56.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.carrev.2019.03.001","type":"journal-article","created":{"date-parts":[[2019,3,13]],"date-time":"2019-03-13T03:17:28Z","timestamp":1552447048000},"page":"78-85","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Outcomes with Drug-Coated Balloons in Percutaneous Coronary Intervention in Diabetic Patients"],"prefix":"10.1016","volume":"21","author":[{"given":"Michael","family":"Megaly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelrahman","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bishoy","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charl","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdi","family":"Zordok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Shaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"Tawadros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bassam S.","family":"Hennawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman","family":"Elbadawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Omer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwan","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.carrev.2019.03.001_bb0005","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0735-1097(02)02025-9","article-title":"Outcomes in diabetics undergoing revascularization: the long and the short of it","volume":"40","author":"Mathew","year":"2002","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.carrev.2019.03.001_bb0010","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0735-1097(02)01971-X","article-title":"Effects of coronary stenting on vessel patency and long-term clinical outcome after percutaneous coronary revascularization in diabetic patients","volume":"40","author":"Van Belle","year":"2002","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.carrev.2019.03.001_bb0015","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1001\/jama.293.12.1501","article-title":"Diabetes and coronary revascularization","volume":"293","author":"Flaherty","year":"2005","journal-title":"JAMA"},{"issue":"04","key":"10.1016\/j.carrev.2019.03.001_bb0020","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0300-8932(02)76616-5","article-title":"Influence of diabetes mellitus on clinical outcome after percutaneous coronary revascularization","volume":"55","author":"Jim\u00e9nez-Navarro","year":"2002","journal-title":"Rev Esp Cardiol"},{"issue":"4","key":"10.1016\/j.carrev.2019.03.001_bb0025","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJM199807233390404","article-title":"Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction","volume":"339","author":"Haffner","year":"1998","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.carrev.2019.03.001_bb0030","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.amjmed.2006.01.023","article-title":"Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials","volume":"119","author":"Bavry","year":"2006","journal-title":"Am J Med"},{"issue":"10","key":"10.1016\/j.carrev.2019.03.001_bb0035","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/eurheartj\/ehn553","article-title":"Late stent malapposition risk is higher after drug-eluting stent compared with bare-metal stent implantation and associates with late stent thrombosis","volume":"31","author":"Hassan","year":"2009","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.carrev.2019.03.001_bb0040","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.ahj.2007.06.005","article-title":"Impact of diabetes mellitus on long-term outcomes in the drug-eluting stent era","volume":"154","author":"Iijima","year":"2007","journal-title":"Am Heart J"},{"issue":"11","key":"10.1016\/j.carrev.2019.03.001_bb0045","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.jacc.2009.09.057","article-title":"Diabetic and nondiabetic patients with left main and\/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents","volume":"55","author":"Banning","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"24","key":"10.1016\/j.carrev.2019.03.001_bb0050","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.jacc.2008.09.010","article-title":"Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study\u2013Part II) Trial","volume":"52","author":"Daemen","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"9591","key":"10.1016\/j.carrev.2019.03.001_bb0055","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(07)61444-5","article-title":"Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis","volume":"370","author":"Stettler","year":"2007","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.carrev.2019.03.001_bb0060","doi-asserted-by":"crossref","first-page":"613","DOI":"10.4244\/EIJV9I5A98","article-title":"Drug-coated balloons for de novo coronary lesions: results from the Valentines II trial","volume":"9","author":"Waksman","year":"2013","journal-title":"EuroIntervention"},{"issue":"3","key":"10.1016\/j.carrev.2019.03.001_bb0065","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00392-014-0775-2","article-title":"Local paclitaxel induces late lumen enlargement in coronary arteries after balloon angioplasty","volume":"104","author":"Kleber","year":"2015","journal-title":"Clin Res Cardiol"},{"issue":"1","key":"10.1016\/j.carrev.2019.03.001_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147057","article-title":"Anatomical and physiological changes after paclitaxel-coated balloon for atherosclerotic de novo coronary lesions: serial IVUS-VH and FFR study","volume":"11","author":"Ann","year":"2016","journal-title":"PLoS One"},{"issue":"20","key":"10.1016\/j.carrev.2019.03.001_bb0075","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1056\/NEJMoa061254","article-title":"Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter","volume":"355","author":"Scheller","year":"2006","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.carrev.2019.03.001_bb0080","doi-asserted-by":"crossref","first-page":"705","DOI":"10.4244\/EIJV7I6A113","article-title":"The Valentines Trial: results of the first one week worldwide multicentre enrolment trial, evaluating the real world usage of the second generation DIOR paclitaxel drug-eluting balloon for in-stent restenosis treatment","volume":"7","author":"Stella","year":"2011","journal-title":"EuroIntervention"},{"issue":"7","key":"10.1016\/j.carrev.2019.03.001_bb0085","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMoa0706356","article-title":"Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg","volume":"358","author":"Tepe","year":"2008","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.carrev.2019.03.001_bb0090","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jcin.2011.11.010","article-title":"Clinical evaluation of a paclitaxel-eluting balloon for treatment of femoropopliteal arterial disease: 12-month results from a multicenter Italian registry","volume":"5","author":"Micari","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"issue":"7","key":"10.1016\/j.carrev.2019.03.001_bb0095","first-page":"256","article-title":"Treatment of Very Small De Novo Coronary Artery Disease With 2.0\u202fmm Drug-Coated Balloons Showed 1-Year Clinical Outcome Comparable With 2.0\u202fmm Drug-Eluting Stents","volume":"30","author":"Sim","year":"2018","journal-title":"J Invasive Cardiol"},{"issue":"15","key":"10.1016\/j.carrev.2019.03.001_bb0100","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.carrev.2019.03.001_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.carrev.2019.03.001_bb0110","unstructured":"Wells G (2011) Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses."},{"key":"10.1016\/j.carrev.2019.03.001_bb0115","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"issue":"7109","key":"10.1016\/j.carrev.2019.03.001_bb0120","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"Bmj"},{"key":"10.1016\/j.carrev.2019.03.001_bb0125","article-title":"Methodological standards for meta-analyses and qualitative systematic reviews of cardiac prevention and treatment studies: a scientific statement from the American Heart Association","volume":"0000000000000523","author":"Rao","year":"2017","journal-title":"Circulation:CIR."},{"key":"10.1016\/j.carrev.2019.03.001_bb0130","doi-asserted-by":"crossref","first-page":"K83","DOI":"10.4244\/EIJV7SKA15","article-title":"Paclitaxel-eluting balloon angioplasty and cobalt-chromium stents versus conventional angioplasty and paclitaxel-eluting stents in the treatment of native coronary artery stenoses in patients with diabetes mellitus","volume":"7","author":"Ali","year":"2011","journal-title":"EuroIntervention"},{"issue":"1","key":"10.1016\/j.carrev.2019.03.001_bb0135","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.carrev.2016.12.008","article-title":"Comparison of paclitaxel drug-eluting balloon and paclitaxel-eluting stent in small coronary vessels in diabetic and nondiabetic patients\u2013results from the BELLO (balloon elution and late loss optimization) trial","volume":"18","author":"Giannini","year":"2017","journal-title":"Cardiovasc Revasc Med"},{"issue":"5","key":"10.1016\/j.carrev.2019.03.001_bb0140","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.carrev.2012.06.001","article-title":"One-year outcome of patients with diabetes mellitus after percutaneous coronary intervention with three different revascularization strategies: results from the Diabetic Argentina Registry (DEAR)","volume":"13","author":"Mieres","year":"2012","journal-title":"Cardiovasc Revasc Med"},{"issue":"3","key":"10.1016\/j.carrev.2019.03.001_bb0145","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/0735-1097(95)00496-3","article-title":"Potential mechanisms promoting restenosis in diabetic patients","volume":"27","author":"Aronson","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2019.03.001_bb0150","first-page":"S48","article-title":"Percutaneous coronary revascularization of diabetic patients in the era of drug-eluting stents","volume":"6","author":"Kereiakes","year":"2005","journal-title":"Rev Cardiovasc Med"},{"issue":"5","key":"10.1016\/j.carrev.2019.03.001_bb0155","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/clpt.2009.8","article-title":"A critical appraisal of the safety and efficacy of drug-eluting stents","volume":"85","author":"Maluenda","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.carrev.2019.03.001_bb0160","first-page":"111.962878","author":"Sakata","year":"2012","journal-title":"Impact of diabetes mellitus on vessel response in the drug-eluting stent era: pooled volumetric intravascular ultrasound analyses Circ Cardiovasc Interv:CIRCINTERVENTIONS"},{"issue":"8","key":"10.1016\/j.carrev.2019.03.001_bb0165","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.jacc.2003.04.004","article-title":"Short-and long-term results after multivessel stenting in diabetic patients","volume":"43","author":"Moses","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.carrev.2019.03.001_bb0170","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1161\/01.CIR.0000116750.63158.94","article-title":"Clinical and angiographic predictors of restenosis after stent deployment in diabetic patients","volume":"109","author":"West","year":"2004","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.carrev.2019.03.001_bb0175","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jcin.2012.11.006","article-title":"Clinical outcome of patients with and without diabetes mellitus after percutaneous coronary intervention with the resolute zotarolimus-eluting stent: 2-year results from the prospectively pooled analysis of the international global RESOLUTE program","volume":"6","author":"Silber","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"issue":"11","key":"10.1016\/j.carrev.2019.03.001_bb0180","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.jcin.2012.06.020","article-title":"Clinical impact of second-generation everolimus-eluting stent compared with first-generation drug-eluting stents in diabetes mellitus patients: insights from a nationwide coronary intervention register","volume":"5","author":"Kedhi","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"issue":"5","key":"10.1016\/j.carrev.2019.03.001_bb0185","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.jcin.2013.12.201","article-title":"Everolimus-eluting xience v\/promus versus zotarolimus-eluting resolute stents in patients with diabetes mellitus","volume":"7","author":"Park","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"issue":"12","key":"10.1016\/j.carrev.2019.03.001_bb0190","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.amjcard.2018.02.034","article-title":"Outcomes in patients with diabetes mellitus according to insulin treatment after percutaneous coronary intervention in the second-generation drug-eluting stent era","volume":"121","author":"Pi","year":"2018","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.carrev.2019.03.001_bb0195","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s40119-016-0064-4","article-title":"Drug-eluting balloons in the treatment of coronary de novo lesions: a comprehensive review","volume":"5","author":"Richelsen","year":"2016","journal-title":"Cardiol Ther"},{"issue":"16","key":"10.1016\/j.carrev.2019.03.001_bb0200","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1136\/hrt.2010.195057","article-title":"Paclitaxel-coated balloon versus drug-eluting stent during PCI of small coronary vessels, a prospective randomised clinical trial. The PICCOLETO study","volume":"96","author":"Cortese","year":"2010","journal-title":"Heart"},{"issue":"10","key":"10.1016\/j.carrev.2019.03.001_bb0205","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1007\/s00392-017-1126-x","article-title":"A multicenter randomized comparison of paclitaxel-coated balloon with plain balloon angioplasty in patients with small vessel disease","volume":"106","author":"Funatsu","year":"2017","journal-title":"Clin Res Cardiol"},{"issue":"2","key":"10.1016\/j.carrev.2019.03.001_bb0210","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3349\/ymj.2016.57.2.337","article-title":"Comparison of paclitaxel-coated balloon treatment and plain old balloon angioplasty for de novo coronary lesions","volume":"57","author":"Her","year":"2016","journal-title":"Yonsei Med J"},{"issue":"5","key":"10.1016\/j.carrev.2019.03.001_bb0215","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/joic.12333","article-title":"Drug-coated balloons: a safe and effective alternative to drug-eluting stents in small vessel coronary artery disease","volume":"29","author":"Sinaga","year":"2016","journal-title":"J Interv Cardiol"},{"key":"10.1016\/j.carrev.2019.03.001_bb0220","doi-asserted-by":"crossref","unstructured":"Megaly M, Rofael M, Saad M, Rezq A, Kohl LP, Kalra A, Shishehbor M, Soukas P, Abbott J, Brilakis ES Outcomes with drug-coated balloons in small-vessel coronary artery disease. Catheter Cardiovasc Interv 0 (0). doi:doi:https:\/\/doi.org\/10.1002\/ccd.27996","DOI":"10.1002\/ccd.27996"},{"issue":"8","key":"10.1016\/j.carrev.2019.03.001_bb0225","doi-asserted-by":"crossref","first-page":"868","DOI":"10.4244\/EIJV11I8A177","article-title":"DANUBIO-a new drug-eluting balloon for the treatment of side branches in bifurcation lesions: six-month angiographic follow-up results of the DEBSIDE trial","volume":"11","author":"Berland","year":"2015","journal-title":"EuroIntervention"},{"issue":"7","key":"10.1016\/j.carrev.2019.03.001_bb0230","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00392-015-0957-6","article-title":"Drug eluting balloons as stand alone procedure for coronary bifurcational lesions: results of the randomized multicenter PEPCAD-BIF trial","volume":"105","author":"Kleber","year":"2016","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.carrev.2019.03.001_bb0235","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4244\/EIJV10I1A10","article-title":"A prospective randomised study of the paclitaxel-coated balloon catheter in bifurcated coronary lesions (BABILON trial): 24-month clinical and angiographic results","volume":"10","author":"M\u00ednguez","year":"2014","journal-title":"EuroIntervention"},{"issue":"6","key":"10.1016\/j.carrev.2019.03.001_bb0240","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00392-014-0671-9","article-title":"Treatment of coronary de novo bifurcation lesions with DCB only strategy","volume":"103","author":"Schulz","year":"2014","journal-title":"Clin Res Cardiol"},{"issue":"11","key":"10.1016\/j.carrev.2019.03.001_bb0245","first-page":"393","article-title":"Outcomes with drug-coated balloons for treating the side branch of coronary bifurcation lesions","volume":"30","author":"Megaly","year":"2018","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.carrev.2019.03.001_bb0250","series-title":"Drug-eluting balloons with provisional bail-out or adjunctive stenting in de novo coronary artery lesions\u2014A systematic review and meta-analysis","author":"Patel","year":"2017"},{"issue":"6","key":"10.1016\/j.carrev.2019.03.001_bb0255","doi-asserted-by":"crossref","first-page":"311","DOI":"10.4330\/wjc.v7.i6.311","article-title":"Preliminary experience with drug-coated balloon angioplasty in primary percutaneous coronary intervention","volume":"7","author":"Ho","year":"2015","journal-title":"World J Cardiol"},{"issue":"4","key":"10.1016\/j.carrev.2019.03.001_bb0260","first-page":"529","article-title":"Angiographic patterns of drug-eluting stent restenosis after treatment with drug-coated balloon versus balloon angioplasty: late lumen loss subgroup analyses of the PEPCAD-DES study","volume":"88","author":"Rittger","year":"2016","journal-title":"Catheter Cardiovasc Interv"},{"issue":"7","key":"10.1016\/j.carrev.2019.03.001_bb0265","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.jcin.2015.01.031","article-title":"Long-term efficacy and safety of paclitaxel-eluting balloon for the treatment of drug-eluting stent restenosis: 3-year results of a randomized controlled trial","volume":"8","author":"Kufner","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"issue":"1","key":"10.1016\/j.carrev.2019.03.001_bb0270","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jacc.2015.04.063","article-title":"A prospective randomized trial of drug-eluting balloons versus everolimus-eluting stents in patients with in-stent restenosis of drug-eluting stents: the RIBS IV randomized clinical trial","volume":"66","author":"Alfonso","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.carrev.2019.03.001_bb0275","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.carrev.2017.03.025","article-title":"Immediate and short-term performance of a novel sirolimus-coated balloon during complex percutaneous coronary interventions. The FAtebenefratelli SIrolimus COated-balloon (FASICO) registry","volume":"18","author":"Cortese","year":"2017","journal-title":"Cardiovasc Revasc Med"},{"issue":"20","key":"10.1016\/j.carrev.2019.03.001_bb0280","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1016\/j.jcin.2017.06.021","article-title":"The SABRE trial (sirolimus angioplasty balloon for coronary in-stent restenosis): angiographic results and 1-year clinical outcomes","volume":"10","author":"Verheye","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"issue":"18 Supplement","key":"10.1016\/j.carrev.2019.03.001_bb0285","first-page":"B158","article-title":"TCT-390 influence of diabetes on the safety and efficacy of sirolimus coated balloon in a real-world multi-centre Nanolut\u00e8 Registry","volume":"68","author":"Dani","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2019.03.001_bb0290","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ijcard.2016.12.176","article-title":"Comparison of outcomes after treatment of in-stent restenosis using newer generation drug-eluting stents versus drug-eluting balloon: patient-level pooled analysis of Korean Multicenter in-Stent Restenosis Registry","volume":"230","author":"Lee","year":"2017","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.carrev.2019.03.001_bb0295","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2014-000064","article-title":"First-generation versus second-generation drug-eluting stents in current clinical practice: updated evidence from a comprehensive meta-analysis of randomised clinical trials comprising 31 379 patients","volume":"1","author":"Navarese","year":"2014","journal-title":"Open Heart"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838919301630?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838919301630?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:17:50Z","timestamp":1761560270000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838919301630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S1553838919301630"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2019.03.001","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes with Drug-Coated Balloons in Percutaneous Coronary Intervention in Diabetic Patients","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2019.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}